Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
City of Hope Medical Center
Takeda
Universität des Saarlandes
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
BeiGene
Columbia University
Takeda
National Cancer Institute (NCI)
Northwestern University
Stanford University
Children's Oncology Group
University of Nebraska
University of Nebraska
City of Hope Medical Center
Seagen Inc.
University of Nebraska
University of Nebraska
Canadian Cancer Trials Group
Hoffmann-La Roche
City of Hope Medical Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Massachusetts General Hospital
Pfizer
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
Seagen Inc.
Northwestern University
Takeda
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Takeda
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Mayo Clinic
M.D. Anderson Cancer Center
Takeda
Children's Oncology Group
Novartis
Mayo Clinic
National Cancer Institute (NCI)